45 Corporate Overview 01 - 23 Statutory Reports 24 - 109 Financial Statements 110 - 263 The products falling under these product groups are usedbycustomersbelonging to the Pharmaceutical industry for various therapeutic categories such as antidepressant, antidiabetic, anti-infective, antifungal, antiretroviral and cardiovascular. The product groups comprise 85 products. Dapsone and acyclovir are some of the active pharmaceutical ingredients (APIs) while carbonates, chloroformates and carbamoyl chloride derivatives are some of the key intermediates. During 2021-22, sales increased by 2% from ` 498 cr to ` 509 cr. Sales in India increased by 2% from ` 300 cr to ` 307 cr. Sales outside India increased by 2% from ` 198 cr to ` 203 cr and formed 40%of the total. Sales of Atul Bioscience Ltd (ABL), a 100% subsidiary company, decreased from ` 143 cr to ` 126 cr. The Company completed one project at the Atul site. The size of the world Pharmaceutical industry is estimated at US$ 1.45 tn, of which the conventional pharmaceutical segment is estimated to be US$ 1.1 tn. Of this, the size of the world API industry is estimated to be US$ 160 bn. Biologics PHARMACEUTICALS AND AROMATICS – I Product groups: API intermediates, Active Pharmaceutical Ingredients, Others are estimated to contribute about 52% of sales of top 100 products by 2022, while oncology will remain the largest therapyareawith sales growingat about 12.7% CAGR. Worldwide pharmaceutical R&D spend is estimated to growby 2.4% CAGR to US$ 181 bn in 2022. There are 20 major companies that dominate the world marketplace. The main user industry, namely, Pharmaceutical is doing well, especially the vertically integrated pharma companies, and meeting the expectations of mankind. The Company along with ABL will participate in this growth by – i) increasing manufacturing efficiencies, II) debottlenecking and adding capacities, iii) introducing new products and iv) forming long-term strategic alliances with other companies. The price and demand of some products have seen inconsistency and are likely to vary widely over the short-term. Fluctuations in foreign exchange may impact sales. US$ 5 tn fell to US$ 3.5 tn in 2020-21 due to the COVID-19 pandemic. This is seen as a temporary dip, as the caloric demand will continue to rise and the crop demand for human consumption and animal feed is expected to double by 2050. The Company will participate in this growth by - i) improving internal efficiencies and working capital management, ii) promoting retail sales, iii) expanding the product portfolio and securing more registrations and iv) evaluating investment opportunities in vertical integration. Floods or famines may adversely affect the demand. Fluctuations in foreign exchange may impact sales realisations. Given that some of these chemicals can be hazardous, it is essential to take due care in their manufacture and use. Registration costs are high in certain countries. Also, high cost of some of the main raw materials can impact the profitability of the business.
RkJQdWJsaXNoZXIy MjA2MDI2